189 related articles for article (PubMed ID: 16182110)
21. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.
Carbone ML; Brégeon J; Devos N; Chadeuf G; Blanchard A; Azizi M; Pacaud P; Jeunemaître X; Loirand G
Hypertension; 2015 Jun; 65(6):1273-8. PubMed ID: 25870189
[TBL] [Abstract][Full Text] [Related]
23. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
[TBL] [Abstract][Full Text] [Related]
24. Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More.
Ravarotto V; Bertoldi G; Stefanelli LF; Nalesso F; Calò LA
Kidney Blood Press Res; 2022; 47(9):556-564. PubMed ID: 35858584
[TBL] [Abstract][Full Text] [Related]
25. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
Calò LA; Davis PA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
[TBL] [Abstract][Full Text] [Related]
26. Regulation of phospholipase C-delta1 by ARGHAP6, a GTPase-activating protein for RhoA: possible role for enhanced activity of phospholipase C in hypertension.
Ochocka AM; Grden M; Sakowicz-Burkiewicz M; Szutowicz A; Pawelczyk T
Int J Biochem Cell Biol; 2008; 40(10):2264-73. PubMed ID: 18434237
[TBL] [Abstract][Full Text] [Related]
27. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
Calò LA; Davis PA; Rossi GP
J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
[TBL] [Abstract][Full Text] [Related]
28. Increaseed expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats.
Ying Z; Jin L; Dorrance AM; Webb RC
Am J Hypertens; 2004 Oct; 17(10):981-5. PubMed ID: 15485764
[TBL] [Abstract][Full Text] [Related]
29. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
30. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G830-7. PubMed ID: 16763289
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
[TBL] [Abstract][Full Text] [Related]
32. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes.
Calò L; Ceolotto G; Milani M; Pagnin E; van den Heuvel LP; Sartori M; Davis PA; Costa R; Semplicini A
Kidney Int; 2001 Sep; 60(3):882-9. PubMed ID: 11532083
[TBL] [Abstract][Full Text] [Related]
33. Clinical and analytical findings in Gitelman's syndrome associated with homozygosity for the c.1925 G>A SLC12A3 mutation.
Coto E; Arriba G; García-Castro M; Santos F; Corao AI; Díaz M; Sánchez Heras M; Basterrechea MA; Tallón S; Alvarez V
Am J Nephrol; 2009; 30(3):218-21. PubMed ID: 19420906
[TBL] [Abstract][Full Text] [Related]
34. Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome.
Maki N; Komatsuda A; Wakui H; Ohtani H; Kigawa A; Aiba N; Hamai K; Motegi M; Yamaguchi A; Imai H; Sawada K
Nephrol Dial Transplant; 2004 Jul; 19(7):1761-6. PubMed ID: 15069170
[TBL] [Abstract][Full Text] [Related]
35. Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.
Tanabe S; Kreutz B; Suzuki N; Kozasa T
Methods Enzymol; 2004; 390():285-94. PubMed ID: 15488184
[TBL] [Abstract][Full Text] [Related]
36. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
Calò LA
Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
[TBL] [Abstract][Full Text] [Related]
37. A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin.
Dubash AD; Wennerberg K; García-Mata R; Menold MM; Arthur WT; Burridge K
J Cell Sci; 2007 Nov; 120(Pt 22):3989-98. PubMed ID: 17971419
[TBL] [Abstract][Full Text] [Related]
38. Evaluating PVALB as a candidate gene for SLC12A3-negative cases of Gitelman's syndrome.
Riveira-Munoz E; Devuyst O; Belge H; Jeck N; Strompf L; Vargas-Poussou R; Jeunemaître X; Blanchard A; Knoers NV; Konrad M; Dahan K
Nephrol Dial Transplant; 2008 Oct; 23(10):3120-5. PubMed ID: 18469313
[TBL] [Abstract][Full Text] [Related]
39. Influence of simulated microgravity on the activation of the small GTPase Rho involved in cytoskeletal formation--molecular cloning and sequencing of bovine leukemia-associated guanine nucleotide exchange factor.
Higashibata A; Imamizo-Sato M; Seki M; Yamazaki T; Ishioka N
BMC Biochem; 2006 Jun; 7():19. PubMed ID: 16803636
[TBL] [Abstract][Full Text] [Related]
40. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
